The notion that obesity-induced inflammation mediates the development of insulin resistance in animal models and humans has been gaining strong support. It has also been shown that immune cells in local tissues, in particular in visceral adipose tissue, play a major role in the regulation of obesity-induced inflammation. Specifically, obesity increases the numbers and activation of proinflammatory immune cells, including M1 macrophages, neutrophils, Th1 CD4 T cells, and CD8 T cells, while simultaneously suppressing anti-inflammatory cells such as M2 macrophages, CD4 regulatory T cells, regulatory B cells, and eosinophils. Recently, however, new cell types have been shown to participate in the development of obesity-induced inflammation and insulin resistance. Some of these cell types also appear to regulate obesity. These cells are natural killer (NK) cells and innate lymphoid cells (ILCs), which are closely related, and invariant natural killer T (iNKT) cells. It should be noted that, although iNKT cells resemble NK cells in name, they are actually a completely different cell type in terms of their development and functions in immunity and metabolism. In this review, we will focus on the roles that these relatively new players in the metabolism field play in obesity-induced insulin resistance and the regulation of obesity.

Citations

Citations to this article as recorded by  

• NK cell-activating receptor NKp46 does not participate in the development of obesity-induced inflammation and insulin resistance
  Gracia Nathalie, Beatriz Dal Santo Francisco Bonamichi, Jieun Kim, Jiwon Jeong, Haneul Kang, Emirrio Reinaldie Hartland, Eveline Eveline, Jongsoon Lee
  Molecules and Cells.2024; 47(3): 100007.     CrossRef
• Adipose tissue macrophage heterogeneity in the single-cell genomics era
  Haneul Kang, Jongsoon Lee
  Molecules and Cells.2024; 47(2): 100031.     CrossRef
• Role of Leptin in Obesity, Cardiovascular Disease, and Type 2 Diabetes
  Teresa Vilariño-García, María Polonio-González, Antonio Pérez-Pérez, Josep Ribalta, Francisco Arrieta, Manuel Aguilar, Juan Obaya, José Gimeno-Orna, Pedro Iglesias, Jorge Navarro, Santiago Durán, Juan Pedro-Botet, Víctor Sánchez-Margalet
  International Journal of Molecular Sciences.2024; 25(4): 2338.     CrossRef
• TRP channels associated with macrophages as targets for the treatment of obese asthma
  Wenzhao Zhu, Dinxi Bai, Wenting Ji, Jing Gao
  Lipids in Health and Disease.2024;[Epub]     CrossRef
• Brief Report: Relationship Between Adiposity and Biomarkers of Aging and Frailty Among Adults Aging With HIV
  Vitor H. F. Oliveira, Amanda L. Willig, Christine Horvat Davey, Thomas W. Buford, Prema Menezes, Edward Cachay, Heidi M. Crane, Greer A. Burkholder, Barbara M. Gripshover, Julia G. Fleming, John D. Cleveland, Allison R. Webel
  JAIDS Journal of Acquired Immune Deficiency Syndromes.2024; 95(4): 377.     CrossRef
• Causal association of obesity with epigenetic aging and telomere length: a bidirectional mendelian randomization study
  Jixin Li, Wenru Wang, Zhenyu Yang, Linjie Qiu, Yan Ren, Dongling Wang, Meijie Li, Wenjie Li, Feng Gao, Jin Zhang
  Lipids in Health and Disease.2024;[Epub]     CrossRef
• Insights into the Roles of Natural Killer Cells in Osteoarthritis
  Chang-Qing Zheng, Ling-Jun Zeng, Zhi-Hong Liu, Chen-Fang Miao, Ling-Yan Yao, Hong-Tao Song, Xiao-Mu Hu, Xin Zhou
  Immunological Investigations.2024; : 1.     CrossRef
• A 30‐color spectral flow cytometry panel for comprehensive analysis of immune cell composition and macrophage subsets in mouse metabolic organs
  Joost M. Lambooij, Tamar Tak, Arnaud Zaldumbide, Bruno Guigas
  Cytometry Part A.2024;[Epub]     CrossRef
• Adipose tissue aging is regulated by an altered immune system
  Yi-Xiang Zhang, Min-Yi Ou, Zi-Han Yang, Yu Sun, Qing-Feng Li, Shuang-Bai Zhou
  Frontiers in Immunology.2023;[Epub]     CrossRef
• The Influence of Maternal Folate Status on Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis
  Ruhan Xu, Shenhao Liu, Zhiqi Zhong, Yifei Guo, Tianqi Xia, Yanyan Chen, Lingling Ding
  Nutrients.2023; 15(12): 2766.     CrossRef
• Gut microbiota, immunity, and bile acid metabolism: decoding metabolic disease interactions
  Qixiang Zhao, Jiayu Wu, Yong Ding, Yanli Pang, Changtao Jiang
  Life Metabolism.2023;[Epub]     CrossRef
• Proteomic Analysis by 4D Label-free MS-PRM Provides Insight into the Role and Regulatory Mechanisms of IL-25 in NK Cells
  Juan Feng, Luoyao Huang, Shuaipeng Yang, Jiasheng Pan, Xiangxing Zhu, Dongsheng Tang
  Protein & Peptide Letters.2023; 30(10): 841.     CrossRef
• No association of natural killer cell number and function in peripheral blood with overweight/obesity and metabolic syndrome in a cohort of young women
  Julia Keilen, Christina Gar, Marietta Rottenkolber, Louise U. Fueessl, Anna T. Joseph, Rika Draenert, Jochen Seissler, Andreas Lechner
  Physiological Reports.2022;[Epub]     CrossRef
• Browning Epicardial Adipose Tissue: Friend or Foe?
  Elisa Doukbi, Astrid Soghomonian, Coralie Sengenès, Shaista Ahmed, Patricia Ancel, Anne Dutour, Bénédicte Gaborit
  Cells.2022; 11(6): 991.     CrossRef
• Synthetic cannabinoid WIN 55,212–2 inhibits growth and induces cell death of oral and pancreatic stem-like/poorly differentiated tumor cells
  Meng-Wei Ko, Barbara Breznik, Emanuela Senjor, Anahid Jewett
  Advances in Cancer Biology - Metastasis.2022; 5: 100043.     CrossRef
• Aldose reductase promotes diet‐induced obesity via induction of senescence in subcutaneous adipose tissue
  Devi Thiagarajan, Nosirudeen Quadri, Shabnam Jawahar, Hylde Zirpoli, Carmen Hurtado del Pozo, Raquel López‐Díez, Syed Nurul Hasan, Gautham Yepuri, Paul F. Gugger, Brian S. Finlin, Philip A. Kern, Kenneth Gabbay, Ann Marie Schmidt, Ravichandran Ramasamy
  Obesity.2022; 30(8): 1647.     CrossRef
• Macrophages, Chronic Inflammation, and Insulin Resistance
  He Li, Ya Meng, Shuwang He, Xiaochuan Tan, Yujia Zhang, Xiuli Zhang, Lulu Wang, Wensheng Zheng
  Cells.2022; 11(19): 3001.     CrossRef
• Ethnicity and the relationship between covid-19 and the herpes simplex viruses
  Peter Bond
  Medical Hypotheses.2021; 146: 110447.     CrossRef
• Association between maternal folate status and gestational diabetes mellitus
  Yan Yang, Zixin Cai, Jingjing Zhang
  Food Science & Nutrition.2021; 9(4): 2042.     CrossRef
• Natural Killer Cells: Friend or Foe in Metabolic Diseases?
  Yi Li, Fangjie Wang, Saber Imani, Ling Tao, Youcai Deng, Yue Cai
  Frontiers in Immunology.2021;[Epub]     CrossRef
• Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis
  Anahid Jewett, Janko Kos, Kawaljit Kaur, Tahmineh Safaei, Christine Sutanto, Wuyang Chen, Paul Wong, Artin Keshishian Namagerdi, Changge Fang, Yuman Fong, Meng-Wei Ko
  Molecular Therapy - Oncolytics.2020; 16: 41.     CrossRef
• NK cells induce hepatic ER stress to promote insulin resistance in obesity through osteopontin production
  Junhua Wu, Danyang Wu, Longyao Zhang, Chuxuan Lin, Jiahao Liao, Ruyin Xie, Zhulin Li, Siyang Wu, Aimin Liu, Weining Hu, Yang Xi, Shizhong Bu, Fuyan Wang
  Journal of Leukocyte Biology.2020; 107(4): 589.     CrossRef
• Concentration of NK cells after β-glucan and vitamin D supplementation in patients with diabetic retinopathy
  Richter Josef, Pohorska Jitka, Závorková Martina, Král Vlastimil, Stiborova Ivana, Dobiasova Rajnohova Lucie, Vetvicka Vaclav
  Folia Microbiologica.2020; 65(4): 755.     CrossRef
• Nutrition, the visceral immune system, and the evolutionary origins of pathogenic obesity
  Mary Jane West-Eberhard
  Proceedings of the National Academy of Sciences.2019; 116(3): 723.     CrossRef
• Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders
  Mohammad Hosein Farzaei, Amit Kumar Singh, Ramesh Kumar, Courtney R. Croley, Abhay K. Pandey, Ericsson Coy-Barrera, Jayanta Kumar Patra, Gitishree Das, Rout George Kerry, Giuseppe Annunziata, Gian Carlo Tenore, Haroon Khan, Matteo Micucci, Roberta Budries
  International Journal of Molecular Sciences.2019; 20(19): 4957.     CrossRef
• Correlations between Body Mass Index, Plasma High-Sensitivity C-Reactive Protein and Lipids in Patients with Schizophrenia
  Ted Boozalis, Sridevi Devaraj, Olaoluwa O. Okusaga
  Psychiatric Quarterly.2019; 90(1): 101.     CrossRef
• Association of maternal folate status in the second trimester of pregnancy with the risk of gestational diabetes mellitus
  Kaipeng Xie, Pengfei Xu, Ziyi Fu, Xiaohong Gu, Hui Li, Xianwei Cui, Lianghui You, Lijun Zhu, Chenbo Ji, Xirong Guo
  Food Science & Nutrition.2019; 7(11): 3759.     CrossRef
• An intracrine view of sex steroids, immunity, and metabolic regulation
  Katya B. Rubinow
  Molecular Metabolism.2018; 15: 92.     CrossRef
• CD4+ T cells in obesity and obesity-associated diseases
  Yueshui Zhao, Ling Lin, Jing Li, Zhangang Xiao, Bo Chen, Lin Wan, Mingxing Li, Xu Wu, Chi Hin Cho, Jing Shen
  Cellular Immunology.2018; 332: 1.     CrossRef
• Natural killer cells target and differentiate cancer stem-like cells/undifferentiated tumors: strategies to optimize their growth and expansion for effective cancer immunotherapy
  Kawaljit Kaur, Milica Perišić Nanut, Meng-Wei Ko, Tahmineh Safaie, Janko Kos, Anahid Jewett
  Current Opinion in Immunology.2018; 51: 170.     CrossRef
• Parallels in Immunometabolic Adipose Tissue Dysfunction with Ageing and Obesity
  William Trim, James E. Turner, Dylan Thompson
  Frontiers in Immunology.2018;[Epub]     CrossRef
• In response to Manuscript AJRI 01‐18‐016 entitled “Regulatory T cells, natural killer cells and obesity in patients with gestational diabetes mellitus”—Kawada T
  Thalita Frutuoso Lobo, Camila de Moraes Borges, Rosiane Mattar, Caio Perez Gomes, Ana Geisa Santos de Ângelo, Karen Piriscila Tezotto Pendeloski, Silvia Daher
  American Journal of Reproductive Immunology.2018;[Epub]     CrossRef
• Endogenous lipid antigens for invariant natural killer T cells hold the reins in adipose tissue homeostasis
  Robert J. van Eijkeren, Olga Krabbe, Marianne Boes, Henk S. Schipper, Eric Kalkhoven
  Immunology.2018; 153(2): 179.     CrossRef
• Regulatory T cells, natural killer cells, and obesity in patients with gestational diabetes mellitus
  Tomoyuki Kawada
  American Journal of Reproductive Immunology.2018;[Epub]     CrossRef
• Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr−/− Mice
  Savitha Subramanian, Leela Goodspeed, Shari Wang, Yilei Ding, Kevin O’Brien, Godfrey Getz, Alan Chait, Catherine Reardon
  International Journal of Molecular Sciences.2018; 19(2): 510.     CrossRef
• The Fat of the Matter: Obesity and Visceral Adiposity in Treated HIV Infection
  Jordan E. Lake
  Current HIV/AIDS Reports.2017; 14(6): 211.     CrossRef
• Cell Type-Specific Immunomodulation Induced by Helminthes: Effect on Metainflammation, Insulin Resistance and Type-2 Diabetes
  Vivekanandhan Aravindhan, Gowrishankar Anand
  The American Journal of Tropical Medicine and Hygiene.2017; 97(6): 1650.     CrossRef

Green tea or green tea extract (GT/GTE) has been demonstrated to reduce insulin resistance and improve glycemic control. However, evidence for this health beneficial effect is inconsistent. This systematic review evaluated the effect of GT/GTE on insulin resistance and glycemic control in people with pre-diabetes/type 2 diabetes mellitus (T2DM). Ovid MEDLINE, Embase, AMED, Web of Science, and the Cochrane Library were searched up to April 2017 for randomised controlled trials of participants with pre-diabetes or T2DM, where the intervention was GT/GTE. Meta-analysis was performed to assess the standardised mean difference (SMD) in biomarkers of insulin resistance and glycemic control between GT/GTE and placebo groups. Six studies (n=382) were pooled into random-effects meta-analysis. Overall, no differences were found between GT/GTE and the placebo for glycosylated hemoglobin (HbA1c: SMD, −0.32; 95% confidence interval [CI], −0.86 to 0.23), homeostatic model assessment for insulin resistance (HOMA-IR: SMD, 0.10; 95% CI, −0.17 to 0.38), fasting insulin (SMD, −0.25; 95% CI, −0.64 to 0.15), and fasting glucose (SMD, −0.10; 95% CI, −0.50 to 0.30). No evidence support the consumption of GT/GTE could reduce the levels of HbA1c, HOMA-IR, fasting insulin, or fasting glucose in people with pre-diabetes/T2DM. However, the studies included were small and of varying quality.

Citations

Citations to this article as recorded by  

• Is breakfast consumption detrimental, unnecessary, or an opportunity for health promotion? A review of cardiometabolic outcomes and functional food choices
  Heitor O. Santos, Grant M. Tinsley
  Diabetes/Metabolism Research and Reviews.2024;[Epub]     CrossRef
• A comparison of the effects of green tea and cocoa on glycaemic control and insulin sensitivity in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
  Hind Mesfer S. Alkhudaydi, Jeremy P.E. Spencer
  Nutrition and Healthy Aging.2024; 9(1): 17.     CrossRef
• Association between green tea intake and digestive system cancer risk in European and East Asian populations: a Mendelian randomization study
  Duorui Nie, Xiaoyu He, Hao Zheng, Deyu Deng, Fanghui He, Ruyi Li, Xiaoting Ni, Shunxiang Li, Fei Xu
  European Journal of Nutrition.2024;[Epub]     CrossRef
• From Gut to Glucose: A Comprehensive Review on Functional Foods and Dietary Interventions for Diabetes Management
  Nirali Patel, Susha Dinesh, Sameer Sharma
  Current Diabetes Reviews.2024;[Epub]     CrossRef
• Gut microbiota as a driver of the interindividual variability of cardiometabolic effects from tea polyphenols
  Qiqiong Li, Tom Van de Wiele
  Critical Reviews in Food Science and Nutrition.2023; 63(11): 1500.     CrossRef
• Recent insights on tea metabolites, their biosynthesis and chemo-preventing effects: A review
  Ramkumar Samynathan, Muthu Thiruvengadam, Shivraj Hariram Nile, Mohammad Ali Shariati, Maksim Rebezov, Raghvendra Kumar Mishra, Baskar Venkidasamy, Sureshkumar Periyasamy, Ill-Min Chung, Mirian Pateiro, José M. Lorenzo
  Critical Reviews in Food Science and Nutrition.2023; 63(18): 3130.     CrossRef
• Tea's anti‐obesity properties, cardiometabolic health‐promoting potentials, bioactive compounds, and adverse effects: A review focusing on white and green teas
  Behnaz Abiri, Shirin Amini, Mahdi Hejazi, Farhad Hosseinpanah, Afshin Zarghi, Faeze Abbaspour, Majid Valizadeh
  Food Science & Nutrition.2023; 11(10): 5818.     CrossRef
• An investigation into the potential action of polyphenols against human Islet Amyloid Polypeptide aggregation in type 2 diabetes
  Anns Mahboob, Degiri Kalana Lasanga Senevirathne, Pradipta Paul, Faisal Nabi, Rizwan Hasan Khan, Ali Chaari
  International Journal of Biological Macromolecules.2023; 225: 318.     CrossRef
• Association between green tea consumption and metabolic syndrome among Korean adults: results from the Health Examinees study
  Hyeonjin Cho, Sunwoo Han, Jiwon Jeong, Hyein Jung, Sangah Shin
  Journal of Nutrition and Health.2023; 56(1): 70.     CrossRef
• Relevance of Indian traditional tisanes in the management of type 2 diabetes mellitus: A review
  Devi Datt Joshi, Lokesh Deb, Bharat G. Somkuwar, Virendra Singh Rana
  Saudi Pharmaceutical Journal.2023; 31(5): 626.     CrossRef
• Evaluation the Effect of Chronic Obestatin Therapy on the Serum Glucose, Insulin And Lipid Levels in Type 2 Diabetic Rats
  Safa Al-Halbouni, Shadi Homsi, Nabil koshji
  The Open Public Health Journal.2023;[Epub]     CrossRef
• Supplementation with a New Standardized Extract of Green and Black Tea Exerts Antiadipogenic Effects and Prevents Insulin Resistance in Mice with Metabolic Syndrome
  Mario De la Fuente-Muñoz, María De la Fuente-Fernández, Marta Román-Carmena, Sara Amor, María C. Iglesias-de la Cruz, Guillermo García-Laínez, Silvia Llopis, Patricia Martorell, David Verdú, Eva Serna, Ángel L. García-Villalón, Sonia I. Guilera, Antonio M
  International Journal of Molecular Sciences.2023; 24(10): 8521.     CrossRef
• The effect of green tea supplementation on the anthropometric outcomes in overweight and obese women: a time and dose-response meta-analysis of randomized controlled trials
  Yiyi Zhang, Nie Tang, Wei Xia, Shaikh Sanjid Seraj, Marcos Pereira, Periyannan Velu, Hui Zhou, Hanshu Yang, Guanggang Du
  Critical Reviews in Food Science and Nutrition.2023; : 1.     CrossRef
• Ampelopsis grossedentata improves type 2 diabetes mellitus through modulating the gut microbiota and bile acid metabolism
  Yu-li Hu, Mei Li, Lei Ding, Chuan Peng, You Wu, Wei Liu, Dan Zhao, Ling-ling Qin, Xiang-yu Guo, Li-li Wu, Tong-hua Liu
  Journal of Functional Foods.2023; 107: 105622.     CrossRef
• Green Tea and Decaffeinated Light Roasted Green Coffee Extract Combination Improved Cardiac Insulin Resistance through Free Fatty Acids and Adiponectin/FAS Pathways Amelioration in Metabolic Syndrome Rat Model
  Mifetika Lukitasari, Mohammad Saifur Rohman, Dwi Adi Nugroho, Mukhamad Nur Kholis, Nila Aisyah Wahyuni, Nashi Widodo
  F1000Research.2023; 10: 990.     CrossRef
• Impact of Polyphenols on Inflammatory and Oxidative Stress Factors in Diabetes Mellitus: Nutritional Antioxidants and Their Application in Improving Antidiabetic Therapy
  Michal Krawczyk, Izabela Burzynska-Pedziwiatr, Lucyna A. Wozniak, Malgorzata Bukowiecka-Matusiak
  Biomolecules.2023; 13(9): 1402.     CrossRef
• Research progress on the antidiabetic activities of tea and its bioactive components
  Jianjian Gao, Dan Chen, Zhiyuan Lin, Jiakun Peng, Shuai Yu, Chuang Zhou, Huimin Jiang, Ruofan Sun, Zhi Lin, Weidong Dai
  Beverage Plant Research.2023;[Epub]     CrossRef
• Identifying Glucose Metabolism Status in Nondiabetic Japanese Adults Using Machine Learning Model with Simple Questionnaire
  Tomoki Uchida, Takeshi Kanamori, Takanori Teramoto, Yuji Nonaka, Hiroki Tanaka, Satoshi Nakamura, Norihito Murayama, Rajesh Kaluri
  Computational and Mathematical Methods in Medicine.2022; 2022: 1.     CrossRef
• Potential Bioactive Components and Health Promotional Benefits of Tea (Camellia sinensis)
  Saptadip Samanta
  Journal of the American Nutrition Association.2022; 41(1): 65.     CrossRef
• A Mendelian Randomization Study of the Effect of Tea Intake on Type 2 Diabetes
  Yanan Zhang, Ruiqing Wang, Xinhua Tang, Yanjun Wang, Ping Guo, Shukang Wang, Jing Liu
  Frontiers in Genetics.2022;[Epub]     CrossRef
• Dietary Supplements for Weight Management: A Narrative Review of Safety and Metabolic Health Benefits
  Eunice Mah, Oliver Chen, DeAnn J. Liska, Jeffrey B. Blumberg
  Nutrients.2022; 14(9): 1787.     CrossRef
• Antioxidative, Anti-Inflammatory, Anti-Obesogenic, and Antidiabetic Properties of Tea Polyphenols—The Positive Impact of Regular Tea Consumption as an Element of Prophylaxis and Pharmacotherapy Support in Endometrial Cancer
  Piotr Olcha, Anna Winiarska-Mieczan, Małgorzata Kwiecień, Łukasz Nowakowski, Andrzej Miturski, Andrzej Semczuk, Bożena Kiczorowska, Krzysztof Gałczyński
  International Journal of Molecular Sciences.2022; 23(12): 6703.     CrossRef
• Herbal tea, a novel adjuvant therapy for treating type 2 diabetes mellitus: A review
  Xiangyuan Zhang, Lili Zhang, Boxun Zhang, Ke Liu, Jun Sun, Qingwei Li, Linhua Zhao
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Green tea and cancer and cardiometabolic diseases: a review of the current epidemiological evidence
  Sarah Krull Abe, Manami Inoue
  European Journal of Clinical Nutrition.2021; 75(6): 865.     CrossRef
• Green and white teas as health-promoting foods
  Daniel Hinojosa-Nogueira, Sergio Pérez-Burillo, Silvia Pastoriza de la Cueva, José Ángel Rufián-Henares
  Food & Function.2021; 12(9): 3799.     CrossRef
• A systematic review and meta-analysis of association between brain-derived neurotrophic factor and type 2 diabetes and glycemic profile
  Milad Davarpanah, Nafiseh Shokri-mashhadi, Rahele Ziaei, Parvane Saneei
  Scientific Reports.2021;[Epub]     CrossRef
• Maltodextrin encapsulation improves thermal and pH stability of green tea extract catechins
  Aimara V. De La Cruz‐Molina, Jesus F. Ayala Zavala, Ariadna T. Bernal Mercado, Manuel R. Cruz Valenzuela, Gustavo A. González‐Aguilar, Jaime Lizardi‐Mendoza, Francisco Brown‐Bojorquez, Brenda A. Silva‐Espinoza
  Journal of Food Processing and Preservation.2021;[Epub]     CrossRef
• Camellia sinensis in Dentistry: Technological Prospection and Scientific Evidence
  Lídia Audrey Rocha Valadas, Rosueti Diógenes de Oliveira Filho, Edilson Martins Rodrigues Neto, Mary Anne Medeiros Bandeira, Marta Maria de França Fonteles, Vanara Florêncio Passos, Ana Cristina de Mello Fiallos, Mara Assef Leitao Lotif, Nara Juliana Cust
  Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1.     CrossRef
• A comprehensive insight into effects of green tea extract in polycystic ovary syndrome: a systematic review
  Vahid Maleki, Ehsaneh Taheri, Parisa Varshosaz, Fatemeh Pourteymour Fard Tabrizi, Jalal Moludi, Hamed Jafari-Vayghan, Mahdi Shadnoush, Seyed Hossein Yahyazadeh Jabbari, Mehri Seifoleslami, Mohammad Alizadeh
  Reproductive Biology and Endocrinology.2021;[Epub]     CrossRef
• Green Tea and Decaffeinated Light Roasted Green Coffee Extract Combination Improved Cardiac Insulin Resistance through Free Fatty Acids and Adiponectin/FAS Pathway Amelioration in Metabolic Syndrome Rat Model
  Mifetika Lukitasari, Mohammad Saifur Rohman, Dwi Adi Nugroho, Mukhamad Nur Kholis, Nila Aisyah Wahyuni, Nashi Widodo
  F1000Research.2021; 10: 990.     CrossRef
• Mechanisms Underlying the Antidiabetic Activities of Polyphenolic Compounds: A Review
  Tina Nie, Garth J. S. Cooper
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Green tea and selenium-enriched green tea ameliorates non-alcoholic fatty liver disease through peripheral 5-hydroxytryptamine signals in high-fat diet-fed mice
  Lin Zhang, Jia-Ying Xu, Ya-Fang Du, Zhang-Min Wang, Jian-Xiang Li, N. Ou-Yang, Yan Wang, Xue-Bin Yin, Li-Qiang Qin
  International Food Research Journal.2021; 28(5): 996.     CrossRef
• Green Tea Consumption May Be Associated with Cardiovascular Disease Risk and Nonalcoholic Fatty Liver Disease in Type 2 Diabetics: A Cross-Sectional Study in Southeast China
  Huan-Huan Yang, Hui Zhou, Wan-Zhan Zhu, Cai-Long Chen, Guo-Chong Chen, Lu-Gang Yu, Li-Qiang Qin
  Journal of Medicinal Food.2020; 23(10): 1120.     CrossRef
• The effect of green coffee extract supplementation on lipid profile: A systematic review of clinical trial and in-vivo studies
  Omid Nikpayam, Amir Hossein Faghfouri, Omid Mohammad Tavakoli-Rouzbehani, Seyyed-Mostafa Jalali, Marziyeh Najafi, Golbon Sohrab
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2020; 14(5): 1521.     CrossRef
• Biological fates of tea polyphenols and their interactions with microbiota in the gastrointestinal tract: implications on health effects
  Tingting Chen, Chung S. Yang
  Critical Reviews in Food Science and Nutrition.2020; 60(16): 2691.     CrossRef
• Effects of Timing of Acute and Consecutive Catechin Ingestion on Postprandial Glucose Metabolism in Mice and Humans
  Masaki Takahashi, Mamiho Ozaki, Miku Tsubosaka, Hyeon-Ki Kim, Hiroyuki Sasaki, Yuji Matsui, Masanobu Hibi, Noriko Osaki, Masashi Miyashita, Shigenobu Shibata
  Nutrients.2020; 12(2): 565.     CrossRef
• Green tea (Camellia sinensis) for the prevention of cancer
  Tommaso Filippini, Marcella Malavolti, Francesca Borrelli, Angelo A Izzo, Susan J Fairweather-Tait, Markus Horneber, Marco Vinceti
  Cochrane Database of Systematic Reviews.2020;[Epub]     CrossRef
• Metabolic Impact of Flavonoids Consumption in Obesity: From Central to Peripheral
  Viviana Sandoval, Hèctor Sanz-Lamora, Giselle Arias, Pedro F. Marrero, Diego Haro, Joana Relat
  Nutrients.2020; 12(8): 2393.     CrossRef
• Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate
  Amir M. Al Hroob, Mohammad H. Abukhalil, Omnia E. Hussein, Ayman M. Mahmoud
  Biomedicine & Pharmacotherapy.2019; 109: 2155.     CrossRef
• Effects and Mechanisms of Tea for the Prevention and Management of Diabetes Mellitus and Diabetic Complications: An Updated Review
  Jin-Ming Meng, Shi-Yu Cao, Xin-Lin Wei, Ren-You Gan, Yuan-Feng Wang, Shu-Xian Cai, Xiao-Yu Xu, Pang-Zhen Zhang, Hua-Bin Li
  Antioxidants.2019; 8(6): 170.     CrossRef
• Improvement in fasting blood sugar, anthropometric measurement and hs-CRP after consumption of epigallocatechin-3-gallate (EGCG) in patients with type 2 diabetes mellitus
  Said Hadi, Meysam Alipour, Vahideh Aghamohammadi, Sahar Shahemi, Fatemeh Ghafouri-Taleghani, Niloufar Pourjavidi, Mona Foroughi, Mackaan Chraqipoor
  Nutrition & Food Science .2019; 50(2): 348.     CrossRef
• The Phosphorylation of IRS1S307 and AktS473 Molecules in Insulin‐Resistant C2C12 Cells Induced with Palmitate Is Influenced by Epigallocatechin Gallate from Green Tea
  Salar Bakhtiyari, Motahareh Zaherara, Karimeh Haghani, Mehrdad Khatami, Ali Rashidinejad
  Lipids.2019; 54(2-3): 141.     CrossRef
• Effect of annatto-extracted tocotrienols and green tea polyphenols on glucose homeostasis and skeletal muscle metabolism in obese male mice
  Eunhee Chung, Salvatore N. Campise, Hayli E. Joiner, Michael D. Tomison, Gurvinder Kaur, Jannette M. Dufour, Lillian Cole, Latha Ramalingam, Naima Moustaid-Moussa, Chwan-Li Shen
  The Journal of Nutritional Biochemistry.2019; 67: 36.     CrossRef
• Studies on the Prevention of Cancer and Cardiometabolic Diseases by Tea: Issues on Mechanisms, Effective Doses, and Toxicities
  Chung S. Yang, Jinsong Zhang
  Journal of Agricultural and Food Chemistry.2019; 67(19): 5446.     CrossRef
• Salvianolic acid B plays an anti-obesity role in high fat diet-induced obese mice by regulating the expression of mRNA, circRNA, and lncRNA
  Tian An, Jing Zhang, Bohan Lv, Yufei Liu, Jiangpinghao Huang, Juan Lian, Yanxiang Wu, Sihua Gao, Guangjian Jiang
  PeerJ.2019; 7: e6506.     CrossRef
• Popular functional foods and herbs for the management of type-2-diabetes mellitus: A comprehensive review with special reference to clinical trials and its proposed mechanism
  Kamesh Venkatakrishnan, Hui-Fang Chiu, Chin-Kun Wang
  Journal of Functional Foods.2019; 57: 425.     CrossRef
• Green Tea Polyphenols Modify the Gut Microbiome in db/db Mice as Co‐Abundance Groups Correlating with the Blood Glucose Lowering Effect
  Tingting Chen, Anna B. Liu, Shili Sun, Nadim J. Ajami, Matthew C. Ross, Hong Wang, Le Zhang, Kenneth Reuhl, Koichi Kobayashi, Janet C. Onishi, Liping Zhao, Chung S. Yang
  Molecular Nutrition & Food Research.2019;[Epub]     CrossRef
• Effect of herbal tea on glycemic control in patients with type 2 diabetes
  Boxun Zhang, Rensong Yue, Xiaoying Huang, Ying Wang, Yayi Jiang, Jiawei Chin
  Medicine.2019; 98(50): e18346.     CrossRef
• Effects of polysaccharides and polyphenolics fractions of Zijuan tea (Camellia sinensis var. kitamura) on α‐glucosidase activity and blood glucose level and glucose tolerance of hyperglycaemic mice
  Dejing Chen, Jingyuan Sun, Weixue Dong, Yixiao Shen, Zhimin Xu
  International Journal of Food Science & Technology.2018; 53(10): 2335.     CrossRef
• Green tea consumption reduces apelin and orexin-A in overweight and obese women with different training modalities
  Rahman Soori, Azadeh Safei, Parisa Pournemati, Amine Ghram
  Sport Sciences for Health.2018; 14(2): 421.     CrossRef
• Green tea consumption and risk of type 2 diabetes in Chinese adults: the Shanghai Women’s Health Study and the Shanghai Men’s Health Study
  Xiaona Liu, Wanghong Xu, Hui Cai, Yu-Tang Gao, Honglan Li, Bu-Tian Ji, Xiang Shu, Thomas Wang, Robert E Gerszten, Wei Zheng, Yong-Bing Xiang, Xiao-Ou Shu
  International Journal of Epidemiology.2018; 47(6): 1887.     CrossRef

Citations

Citations to this article as recorded by  

• Anxious depression in patients with Type 2 Diabetes Mellitus and its relationship with medication adherence and glycemic control
  Tonatiuh Gonzalez Heredia, Leivy Patricia González-Ramírez, Diana Mercedes Hernández-Corona, Eugenio Alejandro Maciel-Hernández
  Global Public Health.2021; 16(3): 460.     CrossRef

Citations

Citations to this article as recorded by  

• Efficacy of Postprandial Exercise in Mitigating Glycemic Responses in Overweight Individuals and Individuals with Obesity and Type 2 Diabetes—A Systematic Review and Meta-Analysis
  Jie Kang, Brian M. Fardman, Nicholas A. Ratamess, Avery D. Faigenbaum, Jill A. Bush
  Nutrients.2023; 15(20): 4489.     CrossRef
• Multifunctional Wearable System that Integrates Sweat‐Based Sensing and Vital‐Sign Monitoring to Estimate Pre‐/Post‐Exercise Glucose Levels
  Yongseok Joseph Hong, Hyunjae Lee, Jaemin Kim, Minha Lee, Hyung Jin Choi, Taeghwan Hyeon, Dae‐Hyeong Kim
  Advanced Functional Materials.2018;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Effect of Ramipril on Cardiac Autonomic Neuropathy in Patients With Type II Diabetes Mellitus
  Chaitali A Chindhalore, Ganesh N Dakhale, Prathamesh H Kamble, Bharatsing D Rathod, Sunita Kumbhalkar, Mrunal S Phatak
  Cureus.2023;[Epub]     CrossRef
• Evaluating treatment options for cardiovascular autonomic neuropathy in patients with diabetes mellitus: a systematic review
  Jasmine KaiLi Goh, Leroy Koh
  Diabetology International.2023; 14(3): 224.     CrossRef
• The effects of alpha lipoic acid (ALA) supplementation on blood pressure in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials
  Mahdi Vajdi, Nooshin Noshadi, Shirin Hassanizadeh, Atefeh Bonyadian, Hooria Seyedhosseini-Ghaheh, Gholamreza Askari
  Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
• Combination Therapy of Alpha-Lipoic Acid, Gliclazide and Ramipril Protects Against Development of Diabetic Cardiomyopathy via Inhibition of TGF-β/Smad Pathway
  George J. Dugbartey, Quinsker L. Wonje, Karl K. Alornyo, Louis Robertson, Ismaila Adams, Vincent Boima, Samuel D. Mensah
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Diabetic Gastroenteropathy: Soothe the Symptoms or Unravel a Cure?
  Sondre Meling, Davide Bertoli, Dag A. Sangnes, Christina Brock, Asbjørn Drewes, Niels Ejskjaer, Georg Dimcevski, Eirik Søfteland
  Current Diabetes Reviews.2022;[Epub]     CrossRef
• Efficacy and safety of oral alpha-lipoic acid supplementation for type 2 diabetes management: a systematic review and dose–response meta-analysis of randomized trials
  Aliyu Tijani Jibril, Ahmad Jayedi, Sakineh Shab-Bidar
  Endocrine Connections.2022;[Epub]     CrossRef
• Cardiac Autonomic Neuropathy in Type 1 and 2 Diabetes: Epidemiology, Pathophysiology, and Management
  Scott Williams, Siddig Abdel Raheim, Muhammad Ilyas Khan, Umme Rubab, Prathap Kanagala, Sizheng Steven Zhao, Anne Marshall, Emily Brown, Uazman Alam
  Clinical Therapeutics.2022; 44(10): 1394.     CrossRef
• An updated systematic review and dose-response meta-analysis of the effects of α-lipoic acid supplementation on glycemic markers in adults
  Mahsa Mahmoudi-Nezhad, Mahdi Vajdi, Mahdieh Abbasalizad Farhangi
  Nutrition.2021; 82: 111041.     CrossRef
• Management of diabetic neuropathy
  Simona Cernea, Itamar Raz
  Metabolism.2021; 123: 154867.     CrossRef
• Effect of alpha-lipoic acid on arterial stiffness parameters in type 2 diabetes mellitus patients with cardiac autonomic neuropathy
  Victoria A. Serhiyenko, Ludmila M. Serhiyenko, Volodymyr B. Sehin, Alexandr A. Serhiyenko
  Endocrine Regulations.2021; 55(4): 224.     CrossRef
• The Role of Alpha-lipoic Acid Supplementation in the Prevention of Diabetes Complications: A Comprehensive Review of Clinical Trials
  Sarah Jeffrey, Punitha Isaac Samraj, Behin Sundara Raj
  Current Diabetes Reviews.2021;[Epub]     CrossRef
• Safety Evaluation of α-Lipoic Acid Supplementation: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Clinical Studies
  Federica Fogacci, Manfredi Rizzo, Christoffer Krogager, Cormac Kennedy, Coralie M.G. Georges, Tamara Knežević, Evangelos Liberopoulos, Alexandre Vallée, Pablo Pérez-Martínez, Eliane F.E. Wenstedt, Agnė Šatrauskienė, Michal Vrablík, Arrigo F.G. Cicero
  Antioxidants.2020; 9(10): 1011.     CrossRef
• Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet
  Vincenza Spallone
  Diabetes & Metabolism Journal.2019; 43(1): 3.     CrossRef
• Alpha-lipoic acid (ALA) supplementation effect on glycemic and inflammatory biomarkers: A Systematic Review and meta- analysis
  Mehran Rahimlou, Maryam Asadi, Nasrin Banaei Jahromi, Anahita Mansoori
  Clinical Nutrition ESPEN.2019; 32: 16.     CrossRef
• Response: Effects of High-Dose α-Lipoic Acid on Heart Rate Variability of Type 2 Diabetes Mellitus Patients with Cardiac Autonomic Neuropathy in Korea (Diabetes Metab J 2017;41:275-83)
  Chong Hwa Kim, Sol Jae Lee, Bong Yun Cha
  Diabetes & Metabolism Journal.2017; 41(5): 420.     CrossRef
• Letter: Effects of High-Dose α-Lipoic Acid on Heart Rate Variability of Type 2 Diabetes Mellitus Patients with Cardiac Autonomic Neuropathy in Korea (Diabetes Metab J2017;41:275-83)
  Jeongmin Lee, Jae Hyoung Cho
  Diabetes & Metabolism Journal.2017; 41(5): 417.     CrossRef

Citations

Citations to this article as recorded by  

• Initial Combination Therapy in Type 2 Diabetes
  Ji Yoon Kim, Nam Hoon Kim
  Endocrinology and Metabolism.2024; 39(1): 23.     CrossRef
• Validation of RSSDI therapeutic wheel with clinical experience of Indian physicians
  Dhruvi Hasnani, Vipul Chavda, Dinesh Agrawal, Bijay Patni, Ashwin David, Sachin Gathe, Rajeev Chawla, Jothydev Kesavadev, Sunil Gupta, Shriji Hasnani, Banshi Saboo
  International Journal of Diabetes in Developing Countries.2022; 42(3): 451.     CrossRef
• Greater Glycemic Burden Is Associated with Further Poorer Glycemic Control in Newly-Diagnosed Type 2 Diabetes Mellitus Patients
  Wei-Lun Wen, Hui-Chun Huang, Hsiu-Chu Lin, Wan-Ching Lo, Szu-Chia Chen, Mei-Yueh Lee
  Nutrients.2022; 14(2): 320.     CrossRef
• Durability of glucose-lowering effect of dulaglutide in patients with type 2 diabetes mellitus: A real-world data study
  Hwi Seung Kim, Yun Kyung Cho, Myung Jin Kim, Chang Hee Jung, Joong-Yeol Park, Woo Je Lee
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Durability of glycaemic control in type 2 diabetes: A systematic review and meta‐analysis for its association with body weight changes
  Danpei Li, HuaJie Zou, Ping Yin, Wenjun Li, Junyu He, Shuyun Wang, Li Huang, Shiying Shao, Yong Chen, Yan Yang, Xuefeng Yu
  Diabetes, Obesity and Metabolism.2021; 23(1): 208.     CrossRef
• Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: AnEast Asianperspective
  Linong Ji, Juliana C. N. Chan, Miao Yu, Kun Ho Yoon, Sin Gon Kim, Sung Hee Choi, Chien‐Ning Huang, Shih Te Tu, Chih‐Yuan Wang, Päivi Maria Paldánius, Wayne H. H. Sheu
  Diabetes, Obesity and Metabolism.2021; 23(1): 3.     CrossRef
• Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study
  Kyoung Jin Kim, Jimi Choi, Jae Hyun Bae, Kyeong Jin Kim, Hye Jin Yoo, Ji A Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim, Nam Hoon Kim
  Diabetes & Metabolism Journal.2021; 45(3): 368.     CrossRef
• Effectiveness of Resistance Training and Associated Program Characteristics in Patients at Risk for Type 2 Diabetes: a Systematic Review and Meta-analysis
  Raza Qadir, Nicholas F. Sculthorpe, Taylor Todd, Elise C. Brown
  Sports Medicine - Open.2021;[Epub]     CrossRef
• Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78)
  Ja Young Jeon
  Diabetes & Metabolism Journal.2021; 45(4): 613.     CrossRef
• Association of Habitual Daily Physical Activity With Glucose Tolerance and β-Cell Function in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes From the Restoring Insulin Secretion (RISE) Study
  Karla A. Temple, Ashley H. Tjaden, Karen M. Atkinson, Elena Barengolts, Tamara S. Hannon, Kieren J. Mather, Kristina M. Utzschneider, Sharon L. Edelstein, David A. Ehrmann, Babak Mokhlesi, Philip S. Zeitler, Jayne Williams, Melanie Cree-Green, Yesenia Gar
  Diabetes Care.2019; 42(8): 1521.     CrossRef
• Factors Associated with Poor Hemoglobin A1c Control in Patients with Type 2 Diabetes
  Salam Alqudah, Anan S. Jarab, Eman A. Alefishat, Fadia Mayyas, Maher Khdour, Sharrel Pinto
  Current Diabetes Reviews.2019; 15(2): 164.     CrossRef

Citations

Citations to this article as recorded by  

• An observational study to evaluate the awareness of drug treatment, prescription pattern, adverse drug reactions, and adherence in patients of major depressive disorder
  Urwashi Indrakumar Parmar, Pranali Puradkar, Kranti Kadam, Firoz Tadavi, Snehalata Gajbhiye, Shirish Joshi, Amitoj Sohal
  Perspectives in Clinical Research.2024; 15(2): 59.     CrossRef
• Association between type 2 diabetes mellitus and depression among Korean midlife women: a cross-sectional analysis study
  You Lee Yang, Eun-Ok Im, Yunmi Kim
  BMC Nursing.2023;[Epub]     CrossRef
• The Effect of Exercise Interventions to Improve Psychosocial Aspects and Glycemic Control in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  Gholam Rasul Mohammad Rahimi, Reza Aminzadeh, Amin Azimkhani, Vahid Saatchian
  Biological Research For Nursing.2022; 24(1): 10.     CrossRef
• Is it time to consider depression as a major complication of type 2 diabetes? Evidence from a large population-based cohort study
  Rossella Messina, Marica Iommi, Paola Rucci, Chiara Reno, Maria Pia Fantini, Carlotta Lunghi, Mattia Altini, Francesca Bravi, Simona Rosa, Antonio Nicolucci, Paolo Di Bartolo
  Acta Diabetologica.2022; 59(1): 95.     CrossRef
• The effects of smoking habit change on the risk of depression–Analysis of data from the Korean National Health Insurance Service
  Ga Eun Kim, Min-ho Kim, Weon-Jeon Lim, Soo In Kim
  Journal of Affective Disorders.2022; 302: 293.     CrossRef
• Association Between Diabetic Retinopathy and Insomnia Risk: A Nationwide Population-Based Study
  Yoo Hyun Um, Tae-Won Kim, Jong-Hyun Jeong, Seung-Chul Hong, Ho-Jun Seo, Kyung-Do Han
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Implication of Melanocortin Receptor Genes in the Familial Comorbidity of Type 2 Diabetes and Depression
  Mutaz Amin, Jurg Ott, Rongling Wu, Teodor T. Postolache, Claudia Gragnoli
  International Journal of Molecular Sciences.2022; 23(15): 8350.     CrossRef
• Nutritional importance of tryptophan for improving treatment in depression and diabetes
  Darakhshan Jabeen Haleem
  Nutrition Reviews.2022; 81(1): 133.     CrossRef
• Depression but not non-persistence to antidiabetic drugs is associated with mortality in type 2 diabetes: A nested case-control study
  Carlotta Lunghi, Arsène Zongo, Isabelle Tardif, Éric Demers, Joël Désiré Relwende Diendéré, Line Guénette
  Diabetes Research and Clinical Practice.2021; 171: 108566.     CrossRef
• Single-session acceptance and commitment therapy (ACT) interventions for patients with chronic health conditions: A systematic review and meta-analysis
  Cara Dochat, Jennalee S. Wooldridge, Matthew S. Herbert, Michael W. Lee, Niloofar Afari
  Journal of Contextual Behavioral Science.2021; 20: 52.     CrossRef
• Population segmentation of type 2 diabetes mellitus patients and its clinical applications - a scoping review
  Jun Jie Benjamin Seng, Amelia Yuting Monteiro, Yu Heng Kwan, Sueziani Binte Zainudin, Chuen Seng Tan, Julian Thumboo, Lian Leng Low
  BMC Medical Research Methodology.2021;[Epub]     CrossRef
• Increased Risk of Cardiovascular Disease and Mortality in Patients with Diabetes and Coexisting Depression: A Nationwide Population-Based Cohort Study
  Inha Jung, Hyemi Kwon, Se Eun Park, Kyung-Do Han, Yong-Gyu Park, Yang-Hyun Kim, Eun-Jung Rhee, Won-Young Lee
  Diabetes & Metabolism Journal.2021; 45(3): 379.     CrossRef
• Spiritual intelligence, mindfulness, emotional dysregulation, depression relationship with mental well-being among persons with diabetes during COVID-19 pandemic
  Wojujutari Kenni Ajele, Teslim Alabi Oladejo, Abimbola A. Akanni, Oyeyemi Bukola Babalola
  Journal of Diabetes & Metabolic Disorders.2021; 20(2): 1705.     CrossRef
• Altered circulatory levels of miR-128, BDNF, cortisol and shortened telomeres in patients with type 2 diabetes and depression
  Paramasivam Prabu, Subramani Poongothai, Coimbatore Subramanian Shanthirani, Ranjit Mohan Anjana, Viswanathan Mohan, Muthuswamy Balasubramanyam
  Acta Diabetologica.2020; 57(7): 799.     CrossRef
• Intervention Strategies for Prevention of Comorbid Depression Among Individuals With Type 2 Diabetes: A Scoping Review
  Eva Guérin, Hamdi Jaafar, Lisa Amrani, Denis Prud'homme, Céline Aguer
  Frontiers in Public Health.2019;[Epub]     CrossRef
• Association between use of oral hypoglycemic agents in Japanese patients with type 2 diabetes mellitus and risk of depression: A retrospective cohort study
  Hayato Akimoto, Kotoe Tezuka, Yayoi Nishida, Tomohiro Nakayama, Yasuo Takahashi, Satoshi Asai
  Pharmacology Research & Perspectives.2019;[Epub]     CrossRef
• Depression and cardiovascular disease in elderly: Current understanding
  Yaxin Zhang, Yujing Chen, Lina Ma
  Journal of Clinical Neuroscience.2018; 47: 1.     CrossRef
• Past and Current Status of Adult Type 2 Diabetes Mellitus Management in Korea: A National Health Insurance Service Database Analysis
  Seung-Hyun Ko, Kyungdo Han, Yong-ho Lee, Junghyun Noh, Cheol-Young Park, Dae-Jung Kim, Chang Hee Jung, Ki-Up Lee, Kyung-Soo Ko
  Diabetes & Metabolism Journal.2018; 42(2): 93.     CrossRef
• Depression and Mortality in Type 2 Diabetes Mellitus
  Seo Young Lee, Sung Hee Choi
  Diabetes & Metabolism Journal.2017; 41(4): 263.     CrossRef

Citations

Citations to this article as recorded by  

• The reversible effects of free fatty acids on sulfonylurea-stimulated insulin secretion are related to the expression and dynamin-mediated endocytosis of KATP channels in pancreatic β cells
  Chenmin Wei, Zichen Zhang, Qi Fu, Yunqiang He, Tao Yang, Min Sun
  Endocrine Connections.2023;[Epub]     CrossRef
• Preparation of fatty acid solutions exerts significant impact on experimental outcomes in cell culture models of lipotoxicity
  Axel Römer, Divya Rawat, Thomas Linn, Sebastian F Petry
  Biology Methods and Protocols.2022;[Epub]     CrossRef
• Lipotoxic Impairment of Mitochondrial Function in β-Cells: A Review
  Axel Römer, Thomas Linn, Sebastian F. Petry
  Antioxidants.2021; 10(2): 293.     CrossRef
• Contribution of Oxidative Stress and Impaired Biogenesis of Pancreatic β-Cells to Type 2 Diabetes
  Petr Ježek, Martin Jabůrek, Lydie Plecitá-Hlavatá
  Antioxidants & Redox Signaling.2019; 31(10): 722.     CrossRef
• The role of polyunsaturated fatty acids (n-3 PUFAs) on the pancreatic β-cells and insulin action
  Habtamu Wondifraw Baynes, Seifu Mideksa, Sintayehu Ambachew
  Adipocyte.2018; : 1.     CrossRef
• Fatty Acid-Stimulated Insulin Secretion vs. Lipotoxicity
  Petr Ježek, Martin Jabůrek, Blanka Holendová, Lydie Plecitá-Hlavatá
  Molecules.2018; 23(6): 1483.     CrossRef

Citations

Citations to this article as recorded by  

• Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: A systematic review
  Annalisa Cespiati, Inês Coelho Rodrigues, Inês Santos, Sara Policarpo, Sofia Carvalhana, Anna Ludovica Fracanzani, Helena Cortez‐Pinto
  Liver International.2024;[Epub]     CrossRef
• Prediction of response to sofosbuvir-based therapy using serum interleukin-12 and single nucleotide polymorphism of the interleukin 28B gene as predictive factors in HCV positive genotype-4 patients
  Doaa Mohamed Abdelnajid, Ahmed Y. Elmowafy, Lionel Rostaing, Marwa T. Elrakaiby
  Medicine.2023; 102(28): e34125.     CrossRef
• Hypoglycemia associated with direct‐acting anti‐hepatitis C virus drugs: An epidemiologic surveillance study of the FDA adverse event reporting system (FAERS)
  Yu Zhou, Wenhuo Xie, Chenhua Zheng, Libin Liu, Zhou Chen, Xiaolu Wang
  Clinical Endocrinology.2022; 96(5): 690.     CrossRef
• Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response
  Sara Cuesta-Sancho, Mercedes Márquez-Coello, Francisco Illanes-Álvarez, Denisse Márquez-Ruiz, Ana Arizcorreta, Fátima Galán-Sánchez, Natalia Montiel, Manuel Rodriguez-Iglesias, José-Antonio Girón-González
  World Journal of Hepatology.2022; 14(1): 62.     CrossRef
• Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel?
  Giorgio Maria Saracco, Alfredo Marzano, Mario Rizzetto
  Biomedicines.2022; 10(3): 534.     CrossRef
• Hépatite B et C: une mise à jour sur lʼhépatite virale chronique
  Marie Ongaro, Francesco Negro
  Schweizer Gastroenterologie.2022; 3(1): 19.     CrossRef
• Effect of achieving sustained virological response with direct-acting antiviral agents on glycemic control in diabetic patients with chronic hepatitis C infection
  Mohamed El-Kassas, Runia El-Folly, Maram Aboromia, Heba Aly, Mohamed Bahgat, Mostafa Hamed
  Egyptian Liver Journal.2022;[Epub]     CrossRef
• Hepatitis C virus infection and diabetes: A complex bidirectional relationship
  Stefano Ciardullo, Alessandro Mantovani, Antonio Ciaccio, Marco Carbone, Pietro Invernizzi, Gianluca Perseghin
  Diabetes Research and Clinical Practice.2022; 187: 109870.     CrossRef
• Does Hepatitis C Virus Treatment by Directly Acting Antivirals Obligate Shifting Patients with Type 2 Diabetes from Oral Hypoglycemic Drugs to Insulin Therapy?
  Rasha Youssef Hagag, Ahmed Fawzy Selim, Omneya Darrag, Hassan Zied, Mohamed Sabry Aboelnasr
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1261.     CrossRef
• Metabolic changes in chronic hepatitis C patients receiving direct acting antivirals
  Nehal K. Abdel Fattah, Sara M. Shaheen, Osama A. Ahmed, Kadry Elsaeed, Nagwa A. Sabri
  F1000Research.2022; 11: 649.     CrossRef
• Hepatitis C virus, insulin resistance, and diabetes: A review
  Nabeel Alzahrani
  Microbiology and Immunology.2022; 66(10): 453.     CrossRef
• The Extent of Insulin Resistance in Patients That Cleared Viral Hepatitis C Infection and the Role of Pre-Existent Type 2 Diabetes Mellitus: A Meta-Analysis
  Marian-Sorin Popescu, Andrei Ioan Drocas, Andrei Osman, Dan-Mihai Firu, Vlad Pădureanu, Cristina Maria Mărginean, Daniel-Cristian Pîrvu, Radu Mitruț, Dragoș Nicolae Mărgăritescu, Antonia Radu, Daniela Calina, Anca Oana Docea, Paul Mitruț
  Reports.2022; 5(4): 42.     CrossRef
• Global longitudinal strain as a predictor of short-term effect of oral antiviral regimens on myocardium in Egyptian patients with chronic viral hepatitis C
  Hazem Mohammad-Ali Farrag, Mina Samir Monir, Wael Soliman Abdel-Dayem, Hisham Abdel-Haleem Ali, Alaa Mohammad Ibrahim
  The Egyptian Heart Journal.2021;[Epub]     CrossRef
• Residual risk of liver disease after hepatitis C virus eradication
  Francesco Negro
  Journal of Hepatology.2021; 74(4): 952.     CrossRef
• Extrahepatic Manifestations of Chronic HCV Infection
  Dan L. Longo, Patrice Cacoub, David Saadoun
  New England Journal of Medicine.2021; 384(11): 1038.     CrossRef
• Metabolic Evaluation in Patients With Hepatitis C Treated With Direct Antiviral Agents
  Sergio Estefan, Carlos Eduardo Brandão-Melo, Cintia Marques dos Santos Silva, Danilo Cosme Klein Gomes, Paula Cardoso, Marcia Helena S. Costa
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Current situation of viral hepatitis in Egypt
  Ashraf Elbahrawy, Marwa K. Ibrahim, Ahmed Eliwa, Mohamed Alboraie, Ali Madian, Hussein Hassan Aly
  Microbiology and Immunology.2021; 65(9): 352.     CrossRef
• The impact of direct-acting antiviral treatment on glycemic homeostasis in patients with chronic hepatitis C
  Marco SACCO, Giorgio M. SARACCO
  Minerva Gastroenterology.2021;[Epub]     CrossRef
• The impact of HCV eradication on hyperglycemia, insulin resistance, cytokine production, and insulin receptor substrate-1 and 2 expression in patients with HCV infection
  Basant Mahmoud, Adel Abdel Moneim, Doaa Mabrouk
  Clinical and Experimental Medicine.2021; 22(4): 583.     CrossRef
• Systematic review: chronic viral hepatitis and metabolic derangement
  Chia‐Chi Wang, Pin‐Nan Cheng, Jia‐Horng Kao
  Alimentary Pharmacology & Therapeutics.2020; 51(2): 216.     CrossRef
• Effect of treatment with direct antiviral agents (DAAs) on glycemic control in patients with type 2 diabetes mellitus & hepatitis C virus genotype 4
  Hassan Yousef Zied, Nashwa Mohamed Abo Alnasr, Amal Said El-Bendary, Sherief Abd-Elsalam, Rasha Youssef Hagag
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2020; 14(4): 679.     CrossRef
• Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus
  Pradeep Kumar Mada, Matthew E. Malus, Arvin Parvathaneni, Bing Chen, Gabriel Castano, Sharon Adley, Maureen Moore, Michinari Hieda, Mohammed J. Alam, Mark Feldman, John William King
  International Journal of Hepatology.2020; 2020: 1.     CrossRef
• Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatments
  Frédéric Clarembeau, Georgia Bale, Nicolas Lanthier
  Clinical Science.2020; 134(16): 2117.     CrossRef
• Treatment of Hepatitis C Virus and Long-Term Effect on Glycemic Control
  Jennifer Andres, Michael Barros, Michael Arutunian, Huaqing Zhao
  Journal of Managed Care & Specialty Pharmacy.2020; 26(6): 775.     CrossRef
• Natural History of Hepatic and Extrahepatic Hepatitis C Virus Diseases and Impact of Interferon-Free HCV Therapy
  Francesco Negro
  Cold Spring Harbor Perspectives in Medicine.2020; 10(4): a036921.     CrossRef
• The Effect of Viral Clearance Achieved by Direct-Acting Antiviral Agents on Hepatitis C Virus Positive Patients with Type 2 Diabetes Mellitus: A Word of Caution after the Initial Enthusiasm
  Davide Giuseppe Ribaldone, Marco Sacco, Giorgio Maria Saracco
  Journal of Clinical Medicine.2020; 9(2): 563.     CrossRef
• Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals
  Riccardo Nevola, Luca Rinaldi, Letizia Zeni, Ferdinando C Sasso, Pia C Pafundi, Barbara Guerrera, Aldo Marrone, Mauro Giordano, Luigi E Adinolfi
  JGH Open.2020; 4(4): 713.     CrossRef
• Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
  Mohamed Mohei El Badry, Doaa Abdelhady Ali, Noha Hamdy Eltaweel, Marwa A. Abdel-Wahed
  Egyptian Liver Journal.2020;[Epub]     CrossRef
• Direct-acting antiviral agents decrease haemoglobin A1c level in patients with diabetes infected with hepatitis C virus: A systematic review & meta-analysis
  Kamolyut Lapumnuaypol, David Pisarcik, Prapaipan Putthapiban, Weera Sukhumthammarat, Karn Wijarnpreecha, Charat Thongprayoon, Patompong Ungprasert
  Indian Journal of Medical Research.2020; 152(6): 562.     CrossRef
• Fisiopatología de la hepatitis C y diabetes mellitus. Hacia la cura de dos epidemias en el siglo XXI
  Harold Ariel Muñoz Díaz, Adán José Lúquez Mindiola, Andrés José Gómez Aldana
  Revista Colombiana de Gastroenterología.2019; 34(3): 277.     CrossRef
• Treatment with direct-acting antivirals improves peripheral insulin sensitivity in non-diabetic, lean chronic hepatitis C patients
  Giacomo Gastaldi, Diana Gomes, Philippe Schneiter, Xavier Montet, Luc Tappy, Sophie Clément, Francesco Negro, Jee-Fu Huang
  PLOS ONE.2019; 14(6): e0217751.     CrossRef
• The impact of a successful treatment of hepatitis C virus on glyco-metabolic control in diabetic patients: a systematic review and meta-analysis
  Carla Carnovale, Marco Pozzi, Alice Dassano, Francesca D’Addio, Marta Gentili, Carlo Magni, Emilio Clementi, Sonia Radice, Paolo Fiorina
  Acta Diabetologica.2019; 56(3): 341.     CrossRef
• Sustained Improvement in Type 2 Diabetes Mellitus is Common After Treatment of Hepatitis C Virus With Direct-acting Antiviral Therapy
  Amir Gilad, Zachary P. Fricker, Adam Hsieh, Dylan D. Thomas, Toni Zahorian, David P. Nunes
  Journal of Clinical Gastroenterology.2019; 53(8): 616.     CrossRef
• Hepatitis C virus infection is associated with hepatic and adipose tissue insulin resistance that improves after viral cure
  Teegan R. Lim, Jonathan M. Hazlehurst, Andrei I. Oprescu, Matthew J. Armstrong, Sewa F. Abdullah, Nigel P. Davies, Robert Flintham, Peter Balfe, David J. Mutimer, Jane A. McKeating, Jeremy W. Tomlinson
  Clinical Endocrinology.2019; 90(3): 440.     CrossRef
• Direct‐acting antivirals for HCV treatment in older patients: A systematic review and meta‐analysis
  Rosanna Villani, Matteo Monami, Francesca Di Cosimo, Gilda Fioravanti, Edoardo Mannucci, Gianluigi Vendemiale, Gaetano Serviddio
  Journal of Viral Hepatitis.2019; 26(11): 1249.     CrossRef
• Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy
  Sylvia Drazilova, Jakub Gazda, Martin Janicko, Peter Jarcuska
  Canadian Journal of Gastroenterology and Hepatology.2018; 2018: 1.     CrossRef
• The comprehensive outcomes of hepatitis C virus infection: A multi‐faceted chronic disease
  Zobair Younossi, Georgios Papatheodoridis, Patrice Cacoub, Francesco Negro, Heiner Wedemeyer, Linda Henry, Angelos Hatzakis
  Journal of Viral Hepatitis.2018; 25(S3): 6.     CrossRef
• Poor glycemic control and abrupt onset of diabetes in HCV patients receiving direct-acting antiviral drugs: case series
  Braira Wahid, Muhammad Wasim, Komal Saleem, Muhammad Waqar, Khansa Wahid, Manzoor Hussain, Muhammad Idrees
  Future Virology.2018; 13(8): 525.     CrossRef
• Risk of diabetes in HIV‐infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort
  A. Provoost, M. Dramé, L. Cotte, L. Cuzin, R. Garraffo, D. Rey, F. Raffi, I. Poizot‐Martin, P. Pugliese, F. Bani‐Sadr
  Alimentary Pharmacology & Therapeutics.2018; 48(3): 281.     CrossRef
• The effect of sustained virological response by direct-acting antivirals on insulin resistance and diabetes mellitus in patients with chronic hepatitis C
  Luigi Elio Adinolfi, Luca Rinaldi, Aldo Marrone, Mauro Giordano
  Expert Review of Anti-infective Therapy.2018; 16(8): 595.     CrossRef
• Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
  Sylvia Drazilova, Martin Janicko, Lubomir Skladany, Pavol Kristian, Marian Oltman, Maria Szantova, Dusan Krkoska, Eva Mazuchova, Lubica Piesecka, Veronika Vahalova, Marek Rac, Ivan Schreter, Ladislav Virag, Tomas Koller, Adriana Liptakova, Miriam Ondrasov
  Canadian Journal of Gastroenterology and Hepatology.2018; 2018: 1.     CrossRef
• INSULIN RESISTANCE REDUCTION AFTER SUSTAINED VIROLOGICAL RESPONSE WITH DIRECT ACTING ANTIVIRAL:NOT EVERY POPULATION IMPROVES
  Vanessa Gutierrez de ANDRADE, Fábio da Silva YAMASHIRO, Cássio Vieira OLIVEIRA, Alecsandro MOREIRA, Fernanda Cristina WINCKLER, Giovanni Faria SILVA
  Arquivos de Gastroenterologia.2018; 55(3): 274.     CrossRef
• Expert Opinion on Managing Chronic HCV Infection in Patients with Type 2 Diabetes Mellitus
  Luigi Elio Adinolf, Ira Jacobson, Mark Bondin, Patrice Cacoub
  Antiviral Therapy.2018; 23(1_suppl): 11.     CrossRef